Release
📈 Stocks
Fondazione Telethon Launches WASKYRA as First US-Approved Wiskott-Aldrich Therapy
(3 minutes ago)
Fondazione Telethon brings WASKYRA to the US market, establishing a new standard of care for Wiskott-Aldrich Syndrome patients as the organization scales…